How to buy Amarin Corporation stock (AMRN)

Amarin Corporation is a drug manufacturers - general business based in the US. Amarin Corporation shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.47 – an increase of 1.33% over the previous week. Amarin Corporation employs 275 staff and has a trailing 12-month revenue of around $241 million.

Our top picks for where to buy Amarin Corporation stock

Buy Amarin Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Amarin Corporation stock price (NASDAQ: AMRN)

Use our graph to track the performance of AMRN stocks over time.

Amarin Corporation shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$0.47
52-week range	$0.45 - $1.37
50-day moving average more info button	$0.56
200-day moving average more info button	$0.73
Wall St. target price	$1.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.10

Is it a good time to buy Amarin Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amarin Corporation price performance over time

Historical closes compared with the close of $0.4553 from 2024-12-13

1 week (2024-12-09)	-9.63%
1 month (2024-11-15)	-8.94%
3 months (2024-09-16)	-22.94%
6 months (2024-06-14)	-41.49%

1 year (2023-12-15)	-45.14%
2 years (2022-12-16)	-63.87%
3 years (2021-12-16)	3.32
5 years (2019-12-16)	22.88

Amarin Corporation financials

Revenue TTM	$241 million
Gross profit TTM	$260.6 million
Return on assets TTM	-3.45%
Return on equity TTM	-7.26%
Profit margin	-16.33%
Book value	$1.29
Market Capitalization more info button	$193.6 million

TTM: trailing 12 months

Amarin Corporation share dividends

We're not expecting Amarin Corporation to pay a dividend over the next 12 months.

Have Amarin Corporation's shares ever split?

Amarin Corporation's shares were split on a 1:10 basis on 17 January 2008 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin Corporation shares which in turn could have impacted Amarin Corporation's share price.

Amarin Corporation share price volatility

Over the last 12 months, Amarin Corporation's shares have ranged in value from as little as $0.4547 up to $1.37. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 1.93. This would suggest that Amarin Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Amarin Corporation overview

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co. , Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.

Frequently asked questions

null
What percentage of Amarin Corporation is owned by insiders or institutions?
Currently 1.602% of Amarin Corporation shares are held by insiders and 17.05% by institutions. How many people work for Amarin Corporation?
Latest data suggests 275 work at Amarin Corporation. When does the fiscal year end for Amarin Corporation?
Amarin Corporation's fiscal year ends in December. Where is Amarin Corporation based?
Amarin Corporation's address is: Iconic Offices, The Greenway, Dublin, Ireland, 112-114 What is Amarin Corporation's ISIN number?
Amarin Corporation's international securities identification number is: US0231112063 What is Amarin Corporation's CUSIP number?
Amarin Corporation's Committee on Uniform Securities Identification Procedures number is: 297645301